Skip to content

A Clinical Trial To Study The Effect Of Lodhra, Tumbiphala Kalka And Lajjalu Kalka As Yonipichu In Pelvic Organ Prolapse

An Open Label Double Arm Comparative Clinical Study To Evaluate The Effect Of Lodhra, Tumbiphala Kalka And Lajjalu Kalka As Yonipichu. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065596
Enrollment
40
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N819- Female genital prolapse, unspecified

Interventions

None listed

Sponsors

Dr Shilpy Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female Patients between 35 and 60 years. (both years inclusive) Uterine Prolapse First And Second Degree Mild To Moderate Rectocele Mild To Moderate Cystocele

Exclusion criteria

Exclusion criteria: Carcinoma of Cervix Any sexually transmitted disease Urethrocele Procedentia Any systemic illness which interferes with the course of treatment

Design outcomes

Primary

MeasureTime frame
Assessment based on subjective parameters Like Mass per vagina along with or without these symptoms as follows- Uterine incontinence, Backache, Dyspareunia, Fecal incontinence, Stress incontinence.Timepoint: Efficacy of treatment will be assessed on the subjective parameters at baseline and the end of 30 days till 60 days.

Secondary

MeasureTime frame
Assessment based on Objective parameters. 1 Prolapse assessed by POP quantification 2 Tenderness assessment of cervical motion tenderness & abdominal tenderness by palpation with visual analog scaleTimepoint: Effect of treatment will be assessed by objective parameters at baseline & the end of 30 days till 60 days

Countries

India

Contacts

Public ContactDR SHILPY SHUKLA

Sri Kalabyraveswara Swamy Ayurvedic Medical College Hospital And Research Centre

dr.anupama.v@gmail.com9845442660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026